Abstract
Reverse phase protein microarrays (RPPA) and laser capture microdissection (LCM) are “sibling” technologies that originated from the same laboratory to overcome the challenge of quantifying low-abundance proteins in heterogeneous tissues. Combining both technologies provides both unique opportunities and unique challenges. Enabling the unprecedented resolution of the activation state of labile biomarkers, such as phosphorylated cell signaling proteins, has had a substantial impact on our understanding of diseases and is playing a significant role in clinical trials. At the same time, quantifying proteins at this sensitivity in very small amounts of material requires cognizance of pre-analytical variability and the limits of downstream detection technologies. Here, we discuss both the potential that the combination of both technologies presents and the potential pitfalls that must be navigated.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Baker AF, Dragovich T, Ihle NT et al (2005) Stability of phosphoprotein as a biological marker of tumor signaling. Clin Cancer Res 11:4338–4340. https://doi.org/10.1158/1078-0432.CCR-05-0422
Barker AD, Sigman CC, Kelloff GJ et al (2009) I-SPY 2: an adaptive breast cancer trial design in the setting of neoadjuvant chemotherapy. Clin Pharmacol Ther 86:97–100. https://doi.org/10.1038/clpt.2009.68
Benton RS, Morris RE (1956) Studies on demineralization of bone. IV. Evaluation of morphology and staining characteristics of tissues after demineralization. Am J Clin Pathol 26:882–898
Bereiter-Hahn J (1972) Laser as a micromanipulator in biology and medicine. 2. Methods and use of laser microirradiation of biological matters. Microsc Acta 72:1–33
Bindhu P, Krishnapillai R, Thomas P, Jayanthi P (2013) Facts in artifacts. J Oral Maxillofac Pathol 17:397–401. https://doi.org/10.4103/0973-029X.125206
Birner P, Toumangelova-Uzeir K, Natchev S, Guentchev M (2010) STAT3 tyrosine phosphorylation influences survival in glioblastoma. J Neuro-Oncol 100:339. https://doi.org/10.1007/s11060-010-0195-8
Burns JA, Li Y, Cheney CA et al (2009) Choice of fixative is crucial to successful immunohistochemical detection of phosphoproteins in paraffin-embedded tumor tissues. J Histochem Cytochem 57:257–264. https://doi.org/10.1369/jhc.2008.952911
Celis JE, Gromov P (2003) Proteomics in translational cancer research: toward an integrated approach. Cancer Cell 3:9–15
Comincini S, Paolillo M, Barbieri G et al (2009) Gene expression analysis of an EGFR indirectly related pathway identified PTEN and MMP9 as reliable diagnostic markers for human glial tumor specimens. J Biomed Biotechnol 2009:1–13. https://doi.org/10.1155/2009/924565
Costa S, Correia-de-Sá P, Porto MJ, Cainé L (2017) The use of laser microdissection in forensic sexual assault casework: pros and cons compared to standard methods. J Forensic Sci 62:998–1006. https://doi.org/10.1111/1556-4029.13348
Datta S, Malhotra L, Dickerson R et al (2015) Laser capture microdissection: big data from small samples. Histol Histopathol 30:1255–1269. https://doi.org/10.14670/HH-11-622
Emmert-Buck MR, Bonner RF, Smith PD et al (1996) Laser capture microdissection. Science 274:998–1001
Espina VA, Edmiston KH, Heiby M et al (2008) A portrait of tissue phosphoprotein stability in the clinical tissue procurement process. Mol Cell Proteomics 7(10):1998–2018
Espina V, Mueller C, Edmiston K et al (2009) Tissue is alive: new technologies are needed to address the problems of protein biomarker pre-analytical variability. Proteomics Clin Appl 3:874–882. https://doi.org/10.1002/prca.200800001
Feng W, Brown RE, Trung CD et al (2008) Morphoproteomic profile of mTOR, Ras/Raf kinase/ERK, and NF-kappaB pathways in human gastric adenocarcinoma. Ann Clin Lab Sci 38:195–209
Fox CH, Johnson FB, Whiting J, Roller PP (1985) Formaldehyde fixation. J Histochem Cytochem 33:845–853
Frost AR, Eltoum I-E, Siegal GP et al (2015) Laser microdissection. Curr Protoc Mol Biol 112:25A.1.1–25A.130. https://doi.org/10.1002/0471142727.mb25a01s112
Gautam V, Sarkar AK (2015) Laser assisted microdissection, an efficient technique to understand tissue specific gene expression patterns and functional genomics in plants. Mol Biotechnol 57:299–308. https://doi.org/10.1007/s12033-014-9824-3
Gilbrich-Wille C (2013) History of laser microdissection
Gimm O, Attié-Bitach T, Lees JA et al (2000) Expression of the PTEN tumour suppressor protein during human development. Hum Mol Genet 9:1633–1639. https://doi.org/10.1093/hmg/9.11.1633
Gorshkov O, Chernova T, Mokshina N et al (2019) Intrusive growth of phloem fibers in flax stem: integrated analysis of miRNA and mRNA expression profiles. Plants (Basel) 8. https://doi.org/10.3390/plants8020047
Grellner W (2002) Time-dependent immunohistochemical detection of proinflammatory cytokines (IL-1beta, IL-6, TNF-alpha) in human skin wounds. Forensic Sci Int 130:90–96
Grellner W, Madea B (2007) Demands on scientific studies: vitality of wounds and wound age estimation. Forensic Sci Int 165:150–154. https://doi.org/10.1016/j.forsciint.2006.05.029
Grellner W, Vieler S, Madea B (2005) Transforming growth factors (TGF-alpha and TGF-beta1) in the determination of vitality and wound age: immunohistochemical study on human skin wounds. Forensic Sci Int 153:174–180. https://doi.org/10.1016/j.forsciint.2004.08.021
Holub D, Flodrova P, Pika T et al (2019) Mass spectrometry amyloid typing is reproducible across multiple organ sites. Biomed Res Int 2019:3689091. https://doi.org/10.1155/2019/3689091
Hunter T (2000) Signaling--2000 and beyond. Cell 100:113–127
Isenberg G, Bielser W, Meier-Ruge W, Remy E (1976) Cell surgery by laser micro-dissection: a preparative method. J Microsc 107:19–24. https://doi.org/10.1111/j.1365-2818.1976.tb02419.x
Jameson GS, Petricoin EF, Sachdev J et al (2014) A pilot study utilizing multi-omic molecular profiling to find potential targets and select individualized treatments for patients with previously treated metastatic breast cancer. Breast Cancer Res Treat 147:579–588. https://doi.org/10.1007/s10549-014-3117-1
Kortz A, Hochholdinger F, Yu P (2019) Cell type-specific transcriptomics of lateral root formation and plasticity. Front Plant Sci 10:21. https://doi.org/10.3389/fpls.2019.00021
Lee P, Wolgemuth CW (2011) Crawling cells can close wounds without purse strings or signaling. PLoS Comput Biol 7:e1002007. https://doi.org/10.1371/journal.pcbi.1002007
Lim MD, Dickherber A, Compton CC (2011) Before you analyze a human specimen, think quality, variability, and bias. Anal Chem 83:8–13. https://doi.org/10.1021/ac1018974
Liu TF, Tatter SB, Willingham MC et al (2003) Growth factor receptor expression varies among high-grade gliomas and normal brain: epidermal growth factor receptor has excellent properties for interstitial fusion protein therapy. Mol Cancer Ther 2:783–787
Louhelainen J, Miller D (2019) Forensic investigation of a shawl linked to the “Jack the ripper” murders. J Forensic Sci. https://doi.org/10.1111/1556-4029.14038
Mueller C, Liotta LA, Espina V (2010) Reverse phase protein microarrays advance to use in clinical trials. Mol Oncol 4:461–481. https://doi.org/10.1016/j.molonc.2010.09.003
Mueller C, Edmiston KH, Carpenter C et al (2011) One-step preservation of phosphoproteins and tissue morphology at room temperature for diagnostic and research specimens. PLoS One 6:e23780. https://doi.org/10.1371/journal.pone.0023780
Mueller C, deCarvalho AC, Mikkelsen T et al (2014) Glioblastoma cell enrichment is critical for analysis of phosphorylated drug targets and proteomic-genomic correlations. Cancer Res 74:818–828. https://doi.org/10.1158/0008-5472.CAN-13-2172
Mueller C, Gambarotti M, Benini S et al (2019) Unlocking bone for proteomic analysis and FISH. Lab Investig 99:708–721. https://doi.org/10.1038/s41374-018-0168-7
Nishizuka S, Charboneau L, Young L et al (2003) Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays. Proc Natl Acad Sci U S A 100:14229–14234. https://doi.org/10.1073/pnas.2331323100
Ostasiewicz P, Zielinska DF, Mann M, Wiśniewski JR (2010) Proteome, phosphoproteome, and N-glycoproteome are quantitatively preserved in formalin-fixed paraffin-embedded tissue and analyzable by high-resolution mass spectrometry. J Proteome Res 9:3688–3700. https://doi.org/10.1021/pr100234w
Paweletz CP, Charboneau L, Bichsel VE et al (2001) Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene 20:1981–1989. https://doi.org/10.1038/sj.onc.1204265
Pierobon M, Silvestri A, Spira A et al (2014) Pilot phase I/II personalized therapy trial for metastatic colorectal cancer: evaluating the feasibility of protein pathway activation mapping for stratifying patients to therapy with imatinib and panitumumab. J Proteome Res 13:2846–2855. https://doi.org/10.1021/pr401267m
Pierobon M, Ramos C, Wong S et al (2017) Enrichment of PI3K-AKT–mTOR pathway activation in hepatic metastases from breast cancer. Clin Cancer Res 23:4919–4928. https://doi.org/10.1158/1078-0432.CCR-16-2656
Podgorny OV, Lazarev VN (2017) Laser microdissection: a promising tool for exploring microorganisms and their interactions with hosts. J Microbiol Methods 138:82–92. https://doi.org/10.1016/j.mimet.2016.01.001
Shankavaram UT, Reinhold WC, Nishizuka S et al (2007) Transcript and protein expression profiles of the NCI-60 cancer cell panel: an integromic microarray study. Mol Cancer Ther 6:820–832. https://doi.org/10.1158/1535-7163.MCT-06-0650
Silvestri A, Colombatti A, Calvert VS et al (2010) Protein pathway biomarker analysis of human cancer reveals requirement for upfront cellular-enrichment processing. Lab Investig 90:787–796. https://doi.org/10.1038/labinvest.2010.47
TCGA Cancers Selected for Study (2018) In: National Cancer Institute. https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/studied-cancers. Accessed 20 May 2019.
Thavarajah R, Mudimbaimannar VK, Elizabeth J et al (2012) Chemical and physical basics of routine formaldehyde fixation. J Oral Maxillofac Pathol JOMFP 16:400. https://doi.org/10.4103/0973-029X.102496
The Cancer Genome Atlase (TCGA) Research Network (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455:1061–1068. https://doi.org/10.1038/nature07385
Tschachotin S (1912) Die mikroskopische Strahlenstichmethode, eine Zelloperationsmethode. In: Biologisches Zentralblatt Georg Thieme, Leipzig, pp 624–630
Vandewoestyne M, Deforce D (2010) Laser capture microdissection in forensic research: a review. Int J Legal Med 124:513–521. https://doi.org/10.1007/s00414-010-0499-4
Viertler C, Groelz D, Gündisch S et al (2012) A new technology for stabilization of biomolecules in tissues for combined histological and molecular analyses. J Mol Diagn 14:458–466. https://doi.org/10.1016/j.jmoldx.2012.05.002
Wolf DM, Yau C, Sanil A et al (2017) DNA repair deficiency biomarkers and the 70-gene ultra-high risk signature as predictors of veliparib/carboplatin response in the I-SPY 2 breast cancer trial. NPJ Breast Cancer 3:31. https://doi.org/10.1038/s41523-017-0025-7
Wulfkuhle JD, Speer R, Pierobon M et al (2008) Multiplexed cell signaling analysis of human breast cancer applications for personalized therapy. J Proteome Res 7:1508–1517. https://doi.org/10.1021/pr7008127
Wulfkuhle JD, Berg D, Wolff C et al (2012) Molecular analysis of HER2 signaling in human breast cancer by functional protein pathway activation mapping. Clin Cancer Res 18:6426–6435. https://doi.org/10.1158/1078-0432.CCR-12-0452
Wulfkuhle JD, Yau C, Wolf DM et al (2018) Evaluation of the HER/PI3K/AKT family signaling network as a predictive biomarker of pathologic complete response for patients with breast cancer treated with Neratinib in the I-SPY 2 TRIAL. JCO Precis Oncol:1–20. https://doi.org/10.1200/PO.18.00024
Yang F, Foekens JA, Yu J et al (2006) Laser microdissection and microarray analysis of breast tumors reveal ER-α related genes and pathways. Oncogene 25:1413–1419. https://doi.org/10.1038/sj.onc.1209165
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Mueller, C., Davis, J.B., Liotta, L.A. (2019). Combining the “Sibling Technologies” of Laser Capture Microdissection and Reverse Phase Protein Microarrays. In: Yamada, T., Nishizuka, S., Mills, G., Liotta, L. (eds) Reverse Phase Protein Arrays. Advances in Experimental Medicine and Biology, vol 1188. Springer, Singapore. https://doi.org/10.1007/978-981-32-9755-5_6
Download citation
DOI: https://doi.org/10.1007/978-981-32-9755-5_6
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-32-9754-8
Online ISBN: 978-981-32-9755-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)